The round was led by technology and healthcare ventures ARCH Venture Partners and Polaris Partners, with the participation of a consumer-only Maveron Venture Fund. This funding round was followed by the Series A round led by Maveron
‘Their knowledge and domain expertise are well aligned with Arivale’s vision and mission-and their insights and analyzes will be invaluable to us in our quest for the future of health and wellness. ”
Arivale uses state-of-the-art science, personalized data and tailored coaching to deliver prioritized, actionable recommendations that inspire clients to achieve and sustain their unique wellness potential. Based on pioneering research by Lee Hood, MD, PhD, founder of the Seattle-based Institute for Systems Biology, Arivale was initially launched in Seattle and will be launched in San Francisco in the fall-expanding to additional markets in 2016.
‘America’s healthcare system focuses almost entirely on diagnosing and treating disease rather than keeping people well,’ said Dr. Hood, who is also co-founder of Arivale and chair of its Scientific Advisory Board (SAB) ‘With Arivale, we will create a new sector-scientific wellness-by leveraging an individual’s unique genetic makeup, clinical laboratory data and lifestyle to optimize wellness and prevent disease. ”
Arivale’s transformative approach to scientific wellness combines a 360-degree view of individual health with personalized coaching to improve life. Arivale is getting to know clients at the deepest level by looking at their genome, blood, saliva, intestinal microbiome and lifestyle data. This information provides millions of personalized data points, but data alone is not enough to improve health. Each client is also connected to the Arivale coach-the Registered Dietitian Nutritionist (RDN)-who works with each client on a regular basis to translate complex scientific information from doctor-ordered laboratory tests into actionable recommendations, to optimize wellness and meet the health objectives of each individual.
‘Arivale empowers people with knowledge and tools to optimize their overall health and wellness in a way that has not been possible before,’ said Clayton Lewis, CEO and co-founder of Arivale. ‘Backed by a team of leading scientists and investors with a strong track record in health, wellness, biotech and high-quality consumer brands, we are launching a new industry-scientific wellness. ”
‘Big science and informed consumers are coming together to drive the sea change that is taking place in healthcare right now,’ said Terry McGuire, founding partner at Polaris Partners. ‘That’s why we wanted to partner with Arivale-it’s at the forefront of this transformation with a bold new approach that is both personalized and comprehensive, enabling individuals to optimize their well-being. ”
Arivale’s approach was refined through a pilot study called the Hundred Person Wellness Project conducted at the Institute for Systems Biology in 2014. The results have confirmed that scientific well-being can improve lives Many participants improved their cardiovascular health and nutrition, while others lowered their risk of diabetes. Overall, 70% of the coaching recommendations were followed up by participants.
‘Arivale has a huge potential to disrupt the current healthcare system through scientific well-being, a completely new industry and an untapped market,’ said Robert Nelsen, co-founder and managing director of ARCH Venture Partners. ‘It is the first company to combine powerful new scientific discoveries with a coaching model that inspires consumers to take action to improve their well-being. ”
‘Arivale is the only company that takes a comprehensive approach to wellness-looking at many different types of data, which is exactly what consumers want today,’ said Dan Levitan, co-founder and managing partner at Maveron. ‘Other companies look at one of these data types or factors in isolation, such as genetics or fitness, and do not offer data integration, nor do they provide personal insights and one-on-one coaching that lead to change. ”
Arivale has also announced the creation of its Scientific Advisory Board (SAB), which will provide strategic guidance on systems biology, technology development, big data, analytics, translational medicine, behavioral science and nutrition. ‘We are excited to launch this company with such a distinguished group of global leaders on our SAB,’ Hood said. ‘Their knowledge and domain expertise are well aligned with Arivale’s vision and mission-and their insights and analyzes will be invaluable to us in our quest for the future of health and wellness. ”
The members of SAB shall include:
Frances Arnold, PhD, Institute of Technology in California
George Church, Ph.D., Harvard Medical College
Robert C’s Green, MD, MPH, Brigham and Women’s Hospital, Harvard Medical School
Jim Heath, Ph.D., California Technology Institute
Lee Hood, MD, PhD, Institute of Systems Biology (chair)
Ed Lazowska, PhD, University of Washington, D.C.
Dr. Larry Smarr, University of California, San Diego.
Ralph Snyderman, MD, University of Duke
Bonnie Spring, PhD, University of Northwestern
Eric Topol, MD, Scripps Research Institute (non-compensated)
About the Arival
Arivale is a scientific wellness company that leverages cutting-edge research, personalized data and tailored coaching to help people optimize wellness and prevent disease. Arivale provides clients with a scientific path to wellness based on their unique genetic makeup, characteristics and lifestyle. Launched in 2015 and based in Seattle, Arivale is supported by leading scientists and investors with a strong track record in health, wellness, biotech breakthroughs and the development of top-notch consumer brands. Visit www to learn more. Arrivale Come and follow us on Twitter and Facebook.
ARCH Venture Partners
ARCH Venture Partners is a leading provider of seed and early-stage capital to technology firms with special expertise in co-founding and building technology firms from start-ups. ARCH invests primarily in companies co-founded with leading scientists and entrepreneurs, focusing on innovations in life sciences, physical sciences and information technology. ARCH is particularly recognized as a leader in the successful commercialization of technologies developed at academic research institutions and national laboratories. ARCH manages eight venture funds totalling $1. 9 billion and has invested in the first round of venture capital for more than 160 companies over almost 30 years. More information can be found at www Archventures Come on,
About the Moveron
Maveron is a consumer-only venture capital company founded in 1998 with offices in Seattle and San Francisco. Since its first investment in eBay, Maveron has been investing in innovative consumer brands along the way, including Zulily, Earnest, General Assembly, Shutterfly, August and most recently Arivale. Visit www for more information on Maveron. Moveron Come on,
About Partners of Polaris
Polaris Partners invests in exceptional technology and healthcare companies at all stages of their life cycles. With offices in Boston, San Francisco and Dublin, we are partnering globally with an unparalleled network of repeat entrepreneurs, top scientists and emerging innovators who make significant contributions in their fields and greatly improve the way we live and work. www www Polaris Partner Come on,
Please note that this piece of work originally appeared in English at https://www.vcnewsdaily.com/Arivale/venture-funding.php. As Investocracy aims to bring global startup news and updates in both English and Japanese to you, it’s important that we attribute original source to you. If you have any questions/concerns please write to us at contact@investocracy.co
